- Home
- MNPR vs FONR Comparison
MNPR vs FONR Comparison
Compare MNPR & FONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- FONR
- Stock Information
- Founded
- MNPR 2014
- FONR 1978
- Country
- MNPR United States
- FONR United States
- Employees
- MNPR 12
- FONR N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MNPR Health Care
- FONR Health Care
- Exchange
- MNPR Nasdaq
- FONR Nasdaq
- Market Cap
- MNPR 292.9M
- FONR 95.7M
- IPO Year
- MNPR 2019
- FONR 1987
- Fundamental
- Price
- MNPR $48.50
- FONR $15.66
- Analyst Decision
- MNPR Strong Buy
- FONR
- Analyst Count
- MNPR 4
- FONR 0
- Target Price
- MNPR $43.00
- FONR N/A
- AVG Volume (30 Days)
- MNPR 67.7K
- FONR 10.3K
- Earning Date
- MNPR 03-27-2025
- FONR 02-12-2025
- Dividend Yield
- MNPR N/A
- FONR N/A
- EPS Growth
- MNPR N/A
- FONR N/A
- EPS
- MNPR N/A
- FONR 1.42
- Revenue
- MNPR N/A
- FONR $102,006,089.00
- Revenue This Year
- MNPR N/A
- FONR N/A
- Revenue Next Year
- MNPR N/A
- FONR N/A
- P/E Ratio
- MNPR N/A
- FONR $10.92
- Revenue Growth
- MNPR N/A
- FONR 0.70
- 52 Week Low
- MNPR $1.55
- FONR $14.05
- 52 Week High
- MNPR $49.98
- FONR $24.05
- Technical
- Relative Strength Index (RSI)
- MNPR 66.31
- FONR 50.12
- Support Level
- MNPR $34.41
- FONR $15.12
- Resistance Level
- MNPR $44.86
- FONR $16.23
- Average True Range (ATR)
- MNPR 5.69
- FONR 0.34
- MACD
- MNPR 1.13
- FONR 0.04
- Stochastic Oscillator
- MNPR 91.91
- FONR 41.67
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About FONR Fonar Corporation
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.